Compare GEHC & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GEHC | WST |
|---|---|---|
| Founded | 1892 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.9B | 25.8B |
| IPO Year | 2022 | 2004 |
| Metric | GEHC | WST |
|---|---|---|
| Price | $65.22 | $361.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 7 |
| Target Price | $88.38 | ★ $325.86 |
| AVG Volume (30 Days) | ★ 4.5M | 682.3K |
| Earning Date | 04-29-2026 | 04-23-2026 |
| Dividend Yield | 0.24% | ★ 0.30% |
| EPS Growth | ★ 4.84 | 1.49 |
| EPS | 0.85 | ★ 1.92 |
| Revenue | ★ $20,625,000,000.00 | $2,886,900,000.00 |
| Revenue This Year | $7.12 | $6.76 |
| Revenue Next Year | $4.45 | $6.22 |
| P/E Ratio | ★ $77.12 | $188.40 |
| Revenue Growth | ★ 4.84 | 1.95 |
| 52 Week Low | $58.75 | $208.71 |
| 52 Week High | $89.77 | $367.66 |
| Indicator | GEHC | WST |
|---|---|---|
| Relative Strength Index (RSI) | 54.59 | 66.09 |
| Support Level | $60.08 | $349.41 |
| Resistance Level | $65.72 | $367.66 |
| Average True Range (ATR) | 1.76 | 7.76 |
| MACD | -0.04 | -0.86 |
| Stochastic Oscillator | 84.88 | 76.20 |
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.